PGL 0.00% 44.0¢ prospa group limited.

broker report says sell with valuation 1.50, page-2

  1. 566 Posts.
    lightbulb Created with Sketch. 44
    isn't nevaxar further behind though?

    Phase 3 trials have not commenced for it yet.

    Also considering Bayer could effectively buy into this technology and own the only 2 post risection liver cancer drugs, I would not discount this yet.

    Charts are looking bearish bigtime.....

    I reckon that extremely price sensitive announcements are coming out this half and it is a good time to capitalise.

    Won't be buying yet.....but soon.

    TheGimp

 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
0.000(0.00%)
Mkt cap ! $72.46M
Open High Low Value Volume
44.0¢ 44.0¢ 44.0¢ $440 1K

Buyers (Bids)

No. Vol. Price($)
7 641986 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 97049 5
View Market Depth
Last trade - 14.50pm 04/07/2024 (20 minute delay) ?
PGL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.